Specific Class I HLA Supertypes but Not HLA Zygosity or Expression Are Associated with Outcomes following HLA-Matched Allogeneic Hematopoietic Cell Transplant: HLA Supertypes Impact Allogeneic HCT Outcomes
Authors:
Open Access
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 27 (2) , 142.e1-142.e11
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- Health Resources and Services Administration
- National Heart, Lung, and Blood Institute
- Leukemia and Lymphoma Society
- National Institutes of Health
This publication has 30 references indexed in Scilit:
- Classification of Human Leukocyte Antigen (HLA) Supertypes2014
- HLA Class I Alleles Are Associated with Peptide-Binding Repertoires of Different Size, Affinity, and ImmunogenicityThe Journal of Immunology, 2013
- Influence of HLA-C Expression Level on HIV ControlScience, 2013
- Human Leukocyte Antigen Class I Supertypes and HIV-1 Control in African AmericansJournal of Virology, 2010
- Advances in the Selection of HLA-Compatible Donors: Refinements in HLA Typing and Matching over the First 20 Years of the National Marrow Donor Program RegistryTransplantation and Cellular Therapy, 2008
- HLA class I supertypes: a revised and updated classificationBMC Immunology, 2008
- Human Leukocyte Antigen B58 Supertype and Human Immunodeficiency Virus Type 1 Infection in Native AfricansJournal of Virology, 2006
- Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDSProceedings of the National Academy of Sciences, 2004
- Advantage of rare HLA supertype in HIV disease progressionNature Medicine, 2003
- The HLA SystemNew England Journal of Medicine, 2000